Chiesi Italia
Chiesi Italia is the Italian affiliate of Chiesi Farmaceutici, an international biopharmaceuticals group.
Recentemente a
www.chiesi.it Descrizione
Chiesi Italia, the Italian branch of the Chiesi Group, is committed to carry out scientific information and market Chiesi products in Italy.
Chiesi is an international research-oriented biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we’re part of a global community of businesses that meet high standards of social and environmental impact. The company aims to reach Net-Zero greenhouse gases (GHG) emissions by 2035. With 90 years of experience, Chiesi is headquartered in Parma (Italy), operates in 31 countries, and counts more than 7,500 employees. The Group has 7 Research and Development centers located in Parma, France, the United States, Canada, China, the UK, and Sweden.
The Impulse is Chiesi’s global Open Innovation initiative, supporting visionary innovators who turn ideas into impactful healthcare solutions. We champion projects that improve patients’ lives, protect the planet, and advance society. Here, ideas grow, partnerships take shape, and meaningful innovations come to life.
